Onconova Therapeutics, Inc. - stock earnings
ONTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -4.7 million USD | 57000 USD |
| 2023Q2 | -4.3 million USD | 57000 USD |
| 2023Q1 | -5.4 million USD | 56000 USD |
| 2022Q4 | -5.0 million USD | 56000 USD |
| 2022Q3 | -5.2 million USD | 57000 USD |
| 2022Q2 | -3.9 million USD | 57000 USD |
| 2022Q1 | -4.1 million USD | 56000 USD |
| 2021Q4 | -3.8 million USD | 56000 USD |
| 2021Q3 | -3.5 million USD | 57000 USD |
| 2021Q2 | -4.2 million USD | 57000 USD |
| 2021Q1 | -4.7 million USD | 56000 USD |
| 2020Q4 | -6.4 million USD | 57000 USD |
| 2020Q3 | -6.2 million USD | 66000 USD |
| 2020Q2 | -7.4 million USD | 56000 USD |
| 2020Q1 | -5.1 million USD | 52000 USD |
| 2019Q4 | -5.7 million USD | 30000 USD |
| 2019Q3 | -4.6 million USD | 63000 USD |
| 2019Q2 | -3.6 million USD | 2.0 million USD |
| 2019Q1 | -5.7 million USD | 59000 USD |
| 2018Q4 | -5.7 million USD | 59000 USD |
| 2018Q3 | -5.3 million USD | 120000 USD |
| 2018Q2 | -4.5 million USD | 485000 USD |
| 2018Q1 | -5.1 million USD | 564000 USD |
| 2017Q4 | -6.2 million USD | 143000 USD |
| 2017Q3 | -7.0 million USD | 110000 USD |
| 2017Q2 | -2.6 million USD | 324000 USD |
| 2017Q1 | -8.3 million USD | 210000 USD |
| 2016Q4 | -5.4 million USD | 173000 USD |
| 2016Q3 | -1.6 million USD | 1.7 million USD |
| 2016Q2 | -5.4 million USD | 2.2 million USD |
| 2016Q1 | -7.2 million USD | 1.5 million USD |
| 2015Q4 | 3.2 million USD | 9.6 million USD |
| 2015Q3 | -5.9 million USD | 1.6 million USD |
| 2015Q2 | -9.0 million USD | 123000 USD |
| 2015Q1 | -12.3 million USD | 114000 USD |
| 2014Q4 | -13.4 million USD | 114000 USD |
| 2014Q3 | -14.9 million USD | 114000 USD |
| 2014Q2 | -16.8 million USD | 125000 USD |
| 2014Q1 | -18.7 million USD | 447000 USD |
| 2013Q4 | -14.6 million USD | 1.9 million USD |
| 2013Q3 | -20.5 million USD | 1.1 million USD |
| 2013Q2 | -12.6 million USD | 591000 USD |
| 2013Q1 | -14.8 million USD | 1.1 million USD |
| 2012Q4 | -10.3 million USD | 3.0 million USD |
| 2012Q3 | -1.4 million USD | 42.8 million USD |
| 2012Q2 | -7.4 million USD | 220000 USD |
| 2012Q1 | -10.8 million USD | 198000 USD |
| 2011Q4 | ? USD | 1.5 million USD |
ONTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -20.2 million USD | 226000 USD |
| 2022 | -18.3 million USD | 226000 USD |
| 2021 | -15.8 million USD | 226000 USD |
| 2020 | -25.2 million USD | 231000 USD |
| 2019 | -21.5 million USD | 2.2 million USD |
| 2018 | -20.6 million USD | 1.2 million USD |
| 2017 | -24.1 million USD | 787000 USD |
| 2016 | -19.7 million USD | 5.5 million USD |
| 2015 | -24.0 million USD | 11.5 million USD |
| 2014 | -63.7 million USD | 800000 USD |
| 2013 | -62.5 million USD | 4.8 million USD |
| 2012 | -29.9 million USD | 46.2 million USD |
| 2011 | -26.3 million USD | 1.5 million USD |
ONTX
Price: $1
52 week price:
Earnings Per Share: -0.96 USD
P/E Ratio: -0.68
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 74400
Ebitda: -6.7 millionMarket Capitalization: 17.6 million